Continuous b-lactam infusion had ⬇️💀 (ARR 1.9%) and ⬆️ clinical cure (ARR 5.7%) vs. intermittent infusion Lillian Kao UTHealthACS Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis jamanetwork.com/journals/jama/…

⬇️ AKI (and stage 3 KDIGO) rates with IV amino acids given over first 72h after CV surgery. However, no difference in needing CRRT/HD. A Randomized Trial of Intravenous Amino Acids for Kidney Protection | New England Journal of Medicine nejm.org/doi/full/10.10…

❇️Best of Trauma❇️ Using a novel multidimensional approach to ACS TQIP data, we identified the highest-performing level I and II trauma centers in the United States. We showed improved discriminatory ability and found significant differences in performance and structural factors

Please pay close attention here. THIS IS WHAT TQIP WAS MADE FOR. It wasn’t constructed so that people could try to pad their CVs with minimal effort by data mining, trying to answer discrete questions that are better answered in MITs or even large single center studies.

Interesting related fact came up in our Trust Trauma Audit today: In the last 5 years at the Royal London, no patient with traumatic cardiac arrest and thoracotomy who survived prehospital & ED phases of care had chest compressions during resuscitation.

Promising adjunct to SSRF and possible substitute in rib fx patients chewing through meds, but poor operative candidates. Lillian Kao UTHealthACS Percutaneous Cryoneurolysis for Pain Control After Rib Fractures in Older Adults jamanetwork.com/journals/jamas…

No difference in overall💀, ICU 💀, or ICU LOS for 1 week continuity attending service vs. 2 weeks Two Weeks Versus One Week of Maximal Patient-Intensivist... : Critical Care Medicine journals.lww.com/ccmjournal/ful…

In this SR/meta, low BP targets (mostly in ICU setting/first 24 hours) had ⬇️ 💀, ⬇️ afib, and ⬇️ transfusions mortality Low Versus High Blood Pressure Targets in Critically Ill... : Critical Care Medicine journals.lww.com/ccmjournal/ful…

Was it the AAs that helped? Or the placebo crystalloids that harmed? 😂 AA infusion x3d in pts undergoing ❤️ surgery+CPB had ⬇️ AKI, stage3 AKI, & RRT A Randomized Trial of Intravenous Amino Acids for Kidney Protection | New England Journal of Medicine nejm.org/doi/full/10.10…

No diff in blood loss/transfusions More complications, including VTE. Shocked. I’m shocked I tell ya! 😂😂😂 Tranexamic Acid in Patients Undergoing Liver Resection: The HeLiX Randomized Clinical Trial | Bleeding and Transfusion | JAMA | JAMA Network jamanetwork.com/journals/jama/…

Look, look!!! Another great TQIP analysis using it for what it was actually meant for… and not some data mining, CV fluffing, re-do 🗑️ of something that’s already been done. Nice work! Beyond American College of Surgeons Verification: Quality... : JACS journals.lww.com/journalacs/abs…

On behalf of McGovern Med School UTHealthACS and the Red Duke Trauma Institute, I’d like to welcome our new Trauma/SCC fellows: -Andrew Fisher from UNM -James Williams from Madigan Army -Shea Gallagher from USC -Henry Caplan from UTH U.S. Army U.S. Army Reserve

Word

DTI after IV thrombolysis for ischemic stroke? No thanks. Higher mortality than adjunct antiplatelet (2x) or placebo (3x). Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke | New England Journal of Medicine nejm.org/doi/full/10.10…

Don’t. Stop. The beta-blocker. 3% absolute risk difference with discontinuation (<0.05). Beta-Blocker Interruption or Continuation after Myocardial Infarction | New England Journal of Medicine nejm.org/doi/full/10.10…

Finally, a DOAC study you can believe in…Drug w/ ⬆️🩸had ⬇️ stroke. Drug w/ ⬇️🩸had ⬆️ stroke. None of these DOACs can honestly be better at both. You’re either a better🩸 thinner, or you’re not. Asundexian vs Apixaban in Patients with Atrial Fib nejm.org/doi/full/10.10…

No need for DAPT De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials - The Lancet thelancet.com/journals/lance…

In ‘05, Bill Riordan was only fellow 2️⃣ stay 4️⃣ 2nd yr fellowship Vanderbilt Trauma. ‘06 graduation, gave him pic below ➕handwritten “Man in the Arena” speech. 2017, started giving 2️⃣ our fellows here UTHealthACS. Been a long 13 yrs, man. The 🌎 was truly better w/ U in it. 👊🥃👊🥃